Ivuxolimab 是一个OX40(也被称为 CD134; TNFRSF4) 激动型单克隆抗体，OX40 是一种表达在活化的 CD4+和 CD8+T 细胞上的共刺激受体。Ivuxolimab 具有抗肿瘤活性，和潜在的免疫刺激活性。
| 生物活性 | Ivuxolimab is anOX40(also known asCD134;TNFRSF4) agonist monoclonal antibody.OX40is a costimulatory receptor expressed on activatedCD4+and CD8+T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity[1]. |
| Clinical Trial | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com